Canine Parvovirus Clinical Trial Completed
Canine Parvovirus Clinical Trial Completed


Progress Level  %100 – Work Completed                                      
Dr Biolyse® Treatment Effectiveness Rate %100
Dr Biolyse®  Group Mortality %0
Standard Treatment Effectiveness Rate %30
Standard Treatment Group Mortality Rate %70

Scope of Treatment Effectiveness:
While the Antiviral effect is observed on the virus,
Deteriorated hematological values ​​returned to normal,
The patients who had completely stopped hemorrhagic diarrhea and vomiting due to infection were discharged.
No serious adverse effects were found.
The clinical trial has been completed.




March 2022